Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.

Van Genechten T, De Laere M, Van den Bossche J, Stein B, De Rycke K, Deschepper C, Hazes K, Peeters R, Couttenye MM, Van De Walle K, Roelant E, Maes S, Vanden Bossche S, Dekeyzer S, Huizing M, Caluwaert K, Nijs G, Cools N, Verlooy J, Norga K, Verhulst S, Anguille S, Berneman Z, Lion E

Open source

DOI: 10.1136/bmjopen-2023-077613
Published: 2024 Mar 18
Container: BMJ open
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1136/bmjopen-2023-077613,
  title = {Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.},
  author = {Van Genechten T and De Laere M and Van den Bossche J and Stein B and De Rycke K and Deschepper C and Hazes K and Peeters R and Couttenye MM and Van De Walle K and Roelant E and Maes S and Vanden Bossche S and Dekeyzer S and Huizing M and Caluwaert K and Nijs G and Cools N and Verlooy J and Norga K and Verhulst S and Anguille S and Berneman Z and Lion E},
  year = {2024},
  journal = {BMJ open},
  doi = {10.1136/bmjopen-2023-077613},
  url = {https://doi.org/10.1136/bmjopen-2023-077613}
}

RIS

TY  - JOUR
TI  - Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.
AU  - Van Genechten T
AU  - De Laere M
AU  - Van den Bossche J
AU  - Stein B
AU  - De Rycke K
AU  - Deschepper C
AU  - Hazes K
AU  - Peeters R
AU  - Couttenye MM
AU  - Van De Walle K
AU  - Roelant E
AU  - Maes S
AU  - Vanden Bossche S
AU  - Dekeyzer S
AU  - Huizing M
AU  - Caluwaert K
AU  - Nijs G
AU  - Cools N
AU  - Verlooy J
AU  - Norga K
AU  - Verhulst S
AU  - Anguille S
AU  - Berneman Z
AU  - Lion E
PY  - 2024
JO  - BMJ open
DO  - 10.1136/bmjopen-2023-077613
UR  - https://doi.org/10.1136/bmjopen-2023-077613
ER  -

APA

T, V. G., M, D. L., J, V. D. B., B, S., K, D. R., C, D., K, H., R, P., MM, C., K, V. D. W., E, R., S, M., S, V. B., S, D., M, H., K, C., G, N., N, C., J, V., K, N., S, V., S, A., Z, B., & E, L. (2024). Adjuvant Wilms' tumour 1-specific dendritic cell immunotherapy complementing conventional therapy for paediatric patients with high-grade glioma and diffuse intrinsic pontine glioma: protocol of a monocentric phase I/II clinical trial in Belgium.. BMJ open. https://doi.org/10.1136/bmjopen-2023-077613

Source records

pubmed · retrieved 2026-09-25T20:24:56.281Z